enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Camidanlumab tesirine - Wikipedia

   en.wikipedia.org/wiki/Camidanlumab_tesirine

   The experimental drug, developed by ADC Therapeutics is being tested in clinical trials for the treatment of B-cell Hodgkin's lymphoma (HL) and non-Hodgkin lymphoma (NHL), and for the treatment of B-cell acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

3. Sintilimab - Wikipedia

   en.wikipedia.org/wiki/Sintilimab

   Currently, more than 20 clinical trials are ongoing to evaluate the anti-tumor effect of sintilimab injection, either as monotherapy or in combination with other agents, on a variety of solid tumors. [10] In January 2019, the result of the registration trial of sintilimab in people with refractory or relapsed classical Hodgkin's lymphoma was ...

4. Stanford V - Wikipedia

   en.wikipedia.org/wiki/Stanford_V

   Stanford V (usually spoken as Stanford Five), is a chemotherapy regimen (with accompanying Radiation therapy) intended as a first-line treatment for Hodgkin lymphoma.The regimen was developed in 1988, with the objective of maintaining a high remission rate while reducing the incidence of acute and long term toxicity, pulmonary damage, and sterility observed in alternative treatment regimens ...

5. Brentuximab vedotin - Wikipedia

   en.wikipedia.org/wiki/Brentuximab_vedotin

   Brentuximab vedotin is also being investigated as a substitute for vincristine (another mitotic inhibitor which prevents tubulin polymerization) in patients with being treated with CHOP (a combination of cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone or prednisolone) for a non-Hodgkin lymphoma. A phase III clinical trial ...

6. ABVD - Wikipedia

   en.wikipedia.org/wiki/ABVD

   A number of trials then compared MOPP vs. MOPP plus ABVD [17] and compared ABVD to previous and other regimens for Hodgkin lymphoma. A large trial by CALGB suggested that ABVD was superior to MOPP, with a higher rate of overall response, less hematologic toxicity, better relapse-free survival, and better outcomes after relapse in the patients ...

7. Nivolumab - Wikipedia

   en.wikipedia.org/wiki/Nivolumab

   Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication used to treat a number of types of cancer. [2] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal ...